Global Gadobutrol (CAS 138071-82-6) Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Gadobutrol (CAS 138071-82-6) will have significant change from previous year. According to our (LP Information) latest study, the global Gadobutrol (CAS 138071-82-6) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Gadobutrol (CAS 138071-82-6) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Gadobutrol (CAS 138071-82-6) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gadobutrol (CAS 138071-82-6) market, reaching US$ million by the year 2028. As for the Europe Gadobutrol (CAS 138071-82-6) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gadobutrol (CAS 138071-82-6) players cover Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma, and Jilin Tely Imp & Exp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gadobutrol (CAS 138071-82-6) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Gadobutrol (CAS 138071-82-6) will have significant change from previous year. According to our (LP Information) latest study, the global Gadobutrol (CAS 138071-82-6) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Gadobutrol (CAS 138071-82-6) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Gadobutrol (CAS 138071-82-6) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gadobutrol (CAS 138071-82-6) market, reaching US$ million by the year 2028. As for the Europe Gadobutrol (CAS 138071-82-6) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gadobutrol (CAS 138071-82-6) players cover Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma, and Jilin Tely Imp & Exp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gadobutrol (CAS 138071-82-6) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
- Pharmacy Bulk Packages (30 mL and 65 mL)
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer HealthCare Pharmaceuticals
- SWAPNROOP DRUGS & PHARMACEUTICALS
- Manus Aktteva Biopharma
- Jilin Tely Imp & Exp
- JinYan Chemicals (ShangHai)
- BOC Sciences
- LGM Pharma
- Advanced Technology & Industrail
- MedKoo Biosciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gadobutrol (CAS 138071-82-6) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gadobutrol (CAS 138071-82-6) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gadobutrol (CAS 138071-82-6) by Country/Region, 2017, 2022 & 2028
2.2 Gadobutrol (CAS 138071-82-6) Segment by Type
2.2.1 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
2.2.2 Pharmacy Bulk Packages (30 mL and 65 mL)
2.3 Gadobutrol (CAS 138071-82-6) Sales by Type
2.3.1 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
2.3.2 Global Gadobutrol (CAS 138071-82-6) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gadobutrol (CAS 138071-82-6) Sale Price by Type (2017-2022)
2.4 Gadobutrol (CAS 138071-82-6) Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Gadobutrol (CAS 138071-82-6) Sales by Application
2.5.1 Global Gadobutrol (CAS 138071-82-6) Sale Market Share by Application (2017-2022)
2.5.2 Global Gadobutrol (CAS 138071-82-6) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gadobutrol (CAS 138071-82-6) Sale Price by Application (2017-2022)
3 GLOBAL GADOBUTROL (CAS 138071-82-6) BY COMPANY
3.1 Global Gadobutrol (CAS 138071-82-6) Breakdown Data by Company
3.1.1 Global Gadobutrol (CAS 138071-82-6) Annual Sales by Company (2020-2022)
3.1.2 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Company (2020-2022)
3.2 Global Gadobutrol (CAS 138071-82-6) Annual Revenue by Company (2020-2022)
3.2.1 Global Gadobutrol (CAS 138071-82-6) Revenue by Company (2020-2022)
3.2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company (2020-2022)
3.3 Global Gadobutrol (CAS 138071-82-6) Sale Price by Company
3.4 Key Manufacturers Gadobutrol (CAS 138071-82-6) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gadobutrol (CAS 138071-82-6) Product Location Distribution
3.4.2 Players Gadobutrol (CAS 138071-82-6) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GADOBUTROL (CAS 138071-82-6) BY GEOGRAPHIC REGION
4.1 World Historic Gadobutrol (CAS 138071-82-6) Market Size by Geographic Region (2017-2022)
4.1.1 Global Gadobutrol (CAS 138071-82-6) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gadobutrol (CAS 138071-82-6) Annual Revenue by Geographic Region
4.2 World Historic Gadobutrol (CAS 138071-82-6) Market Size by Country/Region (2017-2022)
4.2.1 Global Gadobutrol (CAS 138071-82-6) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gadobutrol (CAS 138071-82-6) Annual Revenue by Country/Region
4.3 Americas Gadobutrol (CAS 138071-82-6) Sales Growth
4.4 APAC Gadobutrol (CAS 138071-82-6) Sales Growth
4.5 Europe Gadobutrol (CAS 138071-82-6) Sales Growth
4.6 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Growth
5 AMERICAS
5.1 Americas Gadobutrol (CAS 138071-82-6) Sales by Country
5.1.1 Americas Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022)
5.1.2 Americas Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022)
5.2 Americas Gadobutrol (CAS 138071-82-6) Sales by Type
5.3 Americas Gadobutrol (CAS 138071-82-6) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gadobutrol (CAS 138071-82-6) Sales by Region
6.1.1 APAC Gadobutrol (CAS 138071-82-6) Sales by Region (2017-2022)
6.1.2 APAC Gadobutrol (CAS 138071-82-6) Revenue by Region (2017-2022)
6.2 APAC Gadobutrol (CAS 138071-82-6) Sales by Type
6.3 APAC Gadobutrol (CAS 138071-82-6) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gadobutrol (CAS 138071-82-6) by Country
7.1.1 Europe Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022)
7.1.2 Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022)
7.2 Europe Gadobutrol (CAS 138071-82-6) Sales by Type
7.3 Europe Gadobutrol (CAS 138071-82-6) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gadobutrol (CAS 138071-82-6) by Country
8.1.1 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022)
8.2 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Type
8.3 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gadobutrol (CAS 138071-82-6)
10.3 Manufacturing Process Analysis of Gadobutrol (CAS 138071-82-6)
10.4 Industry Chain Structure of Gadobutrol (CAS 138071-82-6)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gadobutrol (CAS 138071-82-6) Distributors
11.3 Gadobutrol (CAS 138071-82-6) Customer
12 WORLD FORECAST REVIEW FOR GADOBUTROL (CAS 138071-82-6) BY GEOGRAPHIC REGION
12.1 Global Gadobutrol (CAS 138071-82-6) Market Size Forecast by Region
12.1.1 Global Gadobutrol (CAS 138071-82-6) Forecast by Region (2023-2028)
12.1.2 Global Gadobutrol (CAS 138071-82-6) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gadobutrol (CAS 138071-82-6) Forecast by Type
12.7 Global Gadobutrol (CAS 138071-82-6) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bayer HealthCare Pharmaceuticals
13.1.1 Bayer HealthCare Pharmaceuticals Company Information
13.1.2 Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Product Offered
13.1.3 Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer HealthCare Pharmaceuticals Main Business Overview
13.1.5 Bayer HealthCare Pharmaceuticals Latest Developments
13.2 SWAPNROOP DRUGS & PHARMACEUTICALS
13.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Company Information
13.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product Offered
13.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 SWAPNROOP DRUGS & PHARMACEUTICALS Main Business Overview
13.2.5 SWAPNROOP DRUGS & PHARMACEUTICALS Latest Developments
13.3 Manus Aktteva Biopharma
13.3.1 Manus Aktteva Biopharma Company Information
13.3.2 Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Product Offered
13.3.3 Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Manus Aktteva Biopharma Main Business Overview
13.3.5 Manus Aktteva Biopharma Latest Developments
13.4 Jilin Tely Imp & Exp
13.4.1 Jilin Tely Imp & Exp Company Information
13.4.2 Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Product Offered
13.4.3 Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Jilin Tely Imp & Exp Main Business Overview
13.4.5 Jilin Tely Imp & Exp Latest Developments
13.5 JinYan Chemicals (ShangHai)
13.5.1 JinYan Chemicals (ShangHai) Company Information
13.5.2 JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Product Offered
13.5.3 JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 JinYan Chemicals (ShangHai) Main Business Overview
13.5.5 JinYan Chemicals (ShangHai) Latest Developments
13.6 BOC Sciences
13.6.1 BOC Sciences Company Information
13.6.2 BOC Sciences Gadobutrol (CAS 138071-82-6) Product Offered
13.6.3 BOC Sciences Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 BOC Sciences Main Business Overview
13.6.5 BOC Sciences Latest Developments
13.7 LGM Pharma
13.7.1 LGM Pharma Company Information
13.7.2 LGM Pharma Gadobutrol (CAS 138071-82-6) Product Offered
13.7.3 LGM Pharma Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 LGM Pharma Main Business Overview
13.7.5 LGM Pharma Latest Developments
13.8 Advanced Technology & Industrail
13.8.1 Advanced Technology & Industrail Company Information
13.8.2 Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Product Offered
13.8.3 Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Advanced Technology & Industrail Main Business Overview
13.8.5 Advanced Technology & Industrail Latest Developments
13.9 MedKoo Biosciences
13.9.1 MedKoo Biosciences Company Information
13.9.2 MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Product Offered
13.9.3 MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 MedKoo Biosciences Main Business Overview
13.9.5 MedKoo Biosciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gadobutrol (CAS 138071-82-6) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gadobutrol (CAS 138071-82-6) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gadobutrol (CAS 138071-82-6) by Country/Region, 2017, 2022 & 2028
2.2 Gadobutrol (CAS 138071-82-6) Segment by Type
2.2.1 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
2.2.2 Pharmacy Bulk Packages (30 mL and 65 mL)
2.3 Gadobutrol (CAS 138071-82-6) Sales by Type
2.3.1 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
2.3.2 Global Gadobutrol (CAS 138071-82-6) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gadobutrol (CAS 138071-82-6) Sale Price by Type (2017-2022)
2.4 Gadobutrol (CAS 138071-82-6) Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Gadobutrol (CAS 138071-82-6) Sales by Application
2.5.1 Global Gadobutrol (CAS 138071-82-6) Sale Market Share by Application (2017-2022)
2.5.2 Global Gadobutrol (CAS 138071-82-6) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gadobutrol (CAS 138071-82-6) Sale Price by Application (2017-2022)
3 GLOBAL GADOBUTROL (CAS 138071-82-6) BY COMPANY
3.1 Global Gadobutrol (CAS 138071-82-6) Breakdown Data by Company
3.1.1 Global Gadobutrol (CAS 138071-82-6) Annual Sales by Company (2020-2022)
3.1.2 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Company (2020-2022)
3.2 Global Gadobutrol (CAS 138071-82-6) Annual Revenue by Company (2020-2022)
3.2.1 Global Gadobutrol (CAS 138071-82-6) Revenue by Company (2020-2022)
3.2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company (2020-2022)
3.3 Global Gadobutrol (CAS 138071-82-6) Sale Price by Company
3.4 Key Manufacturers Gadobutrol (CAS 138071-82-6) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gadobutrol (CAS 138071-82-6) Product Location Distribution
3.4.2 Players Gadobutrol (CAS 138071-82-6) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GADOBUTROL (CAS 138071-82-6) BY GEOGRAPHIC REGION
4.1 World Historic Gadobutrol (CAS 138071-82-6) Market Size by Geographic Region (2017-2022)
4.1.1 Global Gadobutrol (CAS 138071-82-6) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gadobutrol (CAS 138071-82-6) Annual Revenue by Geographic Region
4.2 World Historic Gadobutrol (CAS 138071-82-6) Market Size by Country/Region (2017-2022)
4.2.1 Global Gadobutrol (CAS 138071-82-6) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gadobutrol (CAS 138071-82-6) Annual Revenue by Country/Region
4.3 Americas Gadobutrol (CAS 138071-82-6) Sales Growth
4.4 APAC Gadobutrol (CAS 138071-82-6) Sales Growth
4.5 Europe Gadobutrol (CAS 138071-82-6) Sales Growth
4.6 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Growth
5 AMERICAS
5.1 Americas Gadobutrol (CAS 138071-82-6) Sales by Country
5.1.1 Americas Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022)
5.1.2 Americas Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022)
5.2 Americas Gadobutrol (CAS 138071-82-6) Sales by Type
5.3 Americas Gadobutrol (CAS 138071-82-6) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gadobutrol (CAS 138071-82-6) Sales by Region
6.1.1 APAC Gadobutrol (CAS 138071-82-6) Sales by Region (2017-2022)
6.1.2 APAC Gadobutrol (CAS 138071-82-6) Revenue by Region (2017-2022)
6.2 APAC Gadobutrol (CAS 138071-82-6) Sales by Type
6.3 APAC Gadobutrol (CAS 138071-82-6) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gadobutrol (CAS 138071-82-6) by Country
7.1.1 Europe Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022)
7.1.2 Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022)
7.2 Europe Gadobutrol (CAS 138071-82-6) Sales by Type
7.3 Europe Gadobutrol (CAS 138071-82-6) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gadobutrol (CAS 138071-82-6) by Country
8.1.1 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022)
8.2 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Type
8.3 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gadobutrol (CAS 138071-82-6)
10.3 Manufacturing Process Analysis of Gadobutrol (CAS 138071-82-6)
10.4 Industry Chain Structure of Gadobutrol (CAS 138071-82-6)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gadobutrol (CAS 138071-82-6) Distributors
11.3 Gadobutrol (CAS 138071-82-6) Customer
12 WORLD FORECAST REVIEW FOR GADOBUTROL (CAS 138071-82-6) BY GEOGRAPHIC REGION
12.1 Global Gadobutrol (CAS 138071-82-6) Market Size Forecast by Region
12.1.1 Global Gadobutrol (CAS 138071-82-6) Forecast by Region (2023-2028)
12.1.2 Global Gadobutrol (CAS 138071-82-6) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gadobutrol (CAS 138071-82-6) Forecast by Type
12.7 Global Gadobutrol (CAS 138071-82-6) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bayer HealthCare Pharmaceuticals
13.1.1 Bayer HealthCare Pharmaceuticals Company Information
13.1.2 Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Product Offered
13.1.3 Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer HealthCare Pharmaceuticals Main Business Overview
13.1.5 Bayer HealthCare Pharmaceuticals Latest Developments
13.2 SWAPNROOP DRUGS & PHARMACEUTICALS
13.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Company Information
13.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product Offered
13.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 SWAPNROOP DRUGS & PHARMACEUTICALS Main Business Overview
13.2.5 SWAPNROOP DRUGS & PHARMACEUTICALS Latest Developments
13.3 Manus Aktteva Biopharma
13.3.1 Manus Aktteva Biopharma Company Information
13.3.2 Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Product Offered
13.3.3 Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Manus Aktteva Biopharma Main Business Overview
13.3.5 Manus Aktteva Biopharma Latest Developments
13.4 Jilin Tely Imp & Exp
13.4.1 Jilin Tely Imp & Exp Company Information
13.4.2 Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Product Offered
13.4.3 Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Jilin Tely Imp & Exp Main Business Overview
13.4.5 Jilin Tely Imp & Exp Latest Developments
13.5 JinYan Chemicals (ShangHai)
13.5.1 JinYan Chemicals (ShangHai) Company Information
13.5.2 JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Product Offered
13.5.3 JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 JinYan Chemicals (ShangHai) Main Business Overview
13.5.5 JinYan Chemicals (ShangHai) Latest Developments
13.6 BOC Sciences
13.6.1 BOC Sciences Company Information
13.6.2 BOC Sciences Gadobutrol (CAS 138071-82-6) Product Offered
13.6.3 BOC Sciences Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 BOC Sciences Main Business Overview
13.6.5 BOC Sciences Latest Developments
13.7 LGM Pharma
13.7.1 LGM Pharma Company Information
13.7.2 LGM Pharma Gadobutrol (CAS 138071-82-6) Product Offered
13.7.3 LGM Pharma Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 LGM Pharma Main Business Overview
13.7.5 LGM Pharma Latest Developments
13.8 Advanced Technology & Industrail
13.8.1 Advanced Technology & Industrail Company Information
13.8.2 Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Product Offered
13.8.3 Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Advanced Technology & Industrail Main Business Overview
13.8.5 Advanced Technology & Industrail Latest Developments
13.9 MedKoo Biosciences
13.9.1 MedKoo Biosciences Company Information
13.9.2 MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Product Offered
13.9.3 MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 MedKoo Biosciences Main Business Overview
13.9.5 MedKoo Biosciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gadobutrol (CAS 138071-82-6) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Gadobutrol (CAS 138071-82-6) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Table 4. Major Players of Pharmacy Bulk Packages (30 mL and 65 mL)
Table 5. Global Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 6. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
Table 7. Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type (2017-2022)
Table 9. Global Gadobutrol (CAS 138071-82-6) Sale Price by Type (2017-2022) & (USD/L)
Table 10. Global Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 11. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Table 12. Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2017-2022)
Table 13. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application (2017-2022)
Table 14. Global Gadobutrol (CAS 138071-82-6) Sale Price by Application (2017-2022) & (USD/L)
Table 15. Global Gadobutrol (CAS 138071-82-6) Sales by Company (2020-2022) & (M L)
Table 16. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Company (2020-2022)
Table 17. Global Gadobutrol (CAS 138071-82-6) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company (2020-2022)
Table 19. Global Gadobutrol (CAS 138071-82-6) Sale Price by Company (2020-2022) & (USD/L)
Table 20. Key Manufacturers Gadobutrol (CAS 138071-82-6) Producing Area Distribution and Sales Area
Table 21. Players Gadobutrol (CAS 138071-82-6) Products Offered
Table 22. Gadobutrol (CAS 138071-82-6) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gadobutrol (CAS 138071-82-6) Sales by Geographic Region (2017-2022) & (M L)
Table 26. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Gadobutrol (CAS 138071-82-6) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Gadobutrol (CAS 138071-82-6) Sales by Country/Region (2017-2022) & (M L)
Table 30. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Gadobutrol (CAS 138071-82-6) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022) & (M L)
Table 34. Americas Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2017-2022)
Table 35. Americas Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2017-2022)
Table 37. Americas Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 38. Americas Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
Table 39. Americas Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 40. Americas Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Table 41. APAC Gadobutrol (CAS 138071-82-6) Sales by Region (2017-2022) & (M L)
Table 42. APAC Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2017-2022)
Table 43. APAC Gadobutrol (CAS 138071-82-6) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2017-2022)
Table 45. APAC Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 46. APAC Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
Table 47. APAC Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 48. APAC Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Table 49. Europe Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022) & (M L)
Table 50. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2017-2022)
Table 51. Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2017-2022)
Table 53. Europe Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 54. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
Table 55. Europe Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 56. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022) & (M L)
Table 58. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 62. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 64. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Gadobutrol (CAS 138071-82-6)
Table 66. Key Market Challenges & Risks of Gadobutrol (CAS 138071-82-6)
Table 67. Key Industry Trends of Gadobutrol (CAS 138071-82-6)
Table 68. Gadobutrol (CAS 138071-82-6) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Gadobutrol (CAS 138071-82-6) Distributors List
Table 71. Gadobutrol (CAS 138071-82-6) Customer List
Table 72. Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Region (2023-2028) & (M L)
Table 73. Global Gadobutrol (CAS 138071-82-6) Sales Market Forecast by Region
Table 74. Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Gadobutrol (CAS 138071-82-6) Sales Forecast by Country (2023-2028) & (M L)
Table 77. Americas Gadobutrol (CAS 138071-82-6) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Gadobutrol (CAS 138071-82-6) Sales Forecast by Region (2023-2028) & (M L)
Table 79. APAC Gadobutrol (CAS 138071-82-6) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Gadobutrol (CAS 138071-82-6) Sales Forecast by Country (2023-2028) & (M L)
Table 81. Europe Gadobutrol (CAS 138071-82-6) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Forecast by Country (2023-2028) & (M L)
Table 83. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Type (2023-2028) & (M L)
Table 85. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Application (2023-2028) & (M L)
Table 89. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bayer HealthCare Pharmaceuticals Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Product Offered
Table 94. Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 95. Bayer HealthCare Pharmaceuticals Main Business
Table 96. Bayer HealthCare Pharmaceuticals Latest Developments
Table 97. SWAPNROOP DRUGS & PHARMACEUTICALS Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 98. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product Offered
Table 99. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 100. SWAPNROOP DRUGS & PHARMACEUTICALS Main Business
Table 101. SWAPNROOP DRUGS & PHARMACEUTICALS Latest Developments
Table 102. Manus Aktteva Biopharma Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 103. Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Product Offered
Table 104. Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 105. Manus Aktteva Biopharma Main Business
Table 106. Manus Aktteva Biopharma Latest Developments
Table 107. Jilin Tely Imp & Exp Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 108. Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Product Offered
Table 109. Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 110. Jilin Tely Imp & Exp Main Business
Table 111. Jilin Tely Imp & Exp Latest Developments
Table 112. JinYan Chemicals (ShangHai) Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 113. JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Product Offered
Table 114. JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 115. JinYan Chemicals (ShangHai) Main Business
Table 116. JinYan Chemicals (ShangHai) Latest Developments
Table 117. BOC Sciences Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 118. BOC Sciences Gadobutrol (CAS 138071-82-6) Product Offered
Table 119. BOC Sciences Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 120. BOC Sciences Main Business
Table 121. BOC Sciences Latest Developments
Table 122. LGM Pharma Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 123. LGM Pharma Gadobutrol (CAS 138071-82-6) Product Offered
Table 124. LGM Pharma Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 125. LGM Pharma Main Business
Table 126. LGM Pharma Latest Developments
Table 127. Advanced Technology & Industrail Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 128. Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Product Offered
Table 129. Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 130. Advanced Technology & Industrail Main Business
Table 131. Advanced Technology & Industrail Latest Developments
Table 132. MedKoo Biosciences Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 133. MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Product Offered
Table 134. MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 135. MedKoo Biosciences Main Business
Table 136. MedKoo Biosciences Latest Developments
Table 1. Gadobutrol (CAS 138071-82-6) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Gadobutrol (CAS 138071-82-6) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Table 4. Major Players of Pharmacy Bulk Packages (30 mL and 65 mL)
Table 5. Global Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 6. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
Table 7. Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type (2017-2022)
Table 9. Global Gadobutrol (CAS 138071-82-6) Sale Price by Type (2017-2022) & (USD/L)
Table 10. Global Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 11. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Table 12. Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2017-2022)
Table 13. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application (2017-2022)
Table 14. Global Gadobutrol (CAS 138071-82-6) Sale Price by Application (2017-2022) & (USD/L)
Table 15. Global Gadobutrol (CAS 138071-82-6) Sales by Company (2020-2022) & (M L)
Table 16. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Company (2020-2022)
Table 17. Global Gadobutrol (CAS 138071-82-6) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company (2020-2022)
Table 19. Global Gadobutrol (CAS 138071-82-6) Sale Price by Company (2020-2022) & (USD/L)
Table 20. Key Manufacturers Gadobutrol (CAS 138071-82-6) Producing Area Distribution and Sales Area
Table 21. Players Gadobutrol (CAS 138071-82-6) Products Offered
Table 22. Gadobutrol (CAS 138071-82-6) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gadobutrol (CAS 138071-82-6) Sales by Geographic Region (2017-2022) & (M L)
Table 26. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Gadobutrol (CAS 138071-82-6) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Gadobutrol (CAS 138071-82-6) Sales by Country/Region (2017-2022) & (M L)
Table 30. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Gadobutrol (CAS 138071-82-6) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022) & (M L)
Table 34. Americas Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2017-2022)
Table 35. Americas Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2017-2022)
Table 37. Americas Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 38. Americas Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
Table 39. Americas Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 40. Americas Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Table 41. APAC Gadobutrol (CAS 138071-82-6) Sales by Region (2017-2022) & (M L)
Table 42. APAC Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2017-2022)
Table 43. APAC Gadobutrol (CAS 138071-82-6) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2017-2022)
Table 45. APAC Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 46. APAC Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
Table 47. APAC Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 48. APAC Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Table 49. Europe Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022) & (M L)
Table 50. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2017-2022)
Table 51. Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2017-2022)
Table 53. Europe Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 54. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
Table 55. Europe Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 56. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Country (2017-2022) & (M L)
Table 58. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Type (2017-2022) & (M L)
Table 62. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Application (2017-2022) & (M L)
Table 64. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Gadobutrol (CAS 138071-82-6)
Table 66. Key Market Challenges & Risks of Gadobutrol (CAS 138071-82-6)
Table 67. Key Industry Trends of Gadobutrol (CAS 138071-82-6)
Table 68. Gadobutrol (CAS 138071-82-6) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Gadobutrol (CAS 138071-82-6) Distributors List
Table 71. Gadobutrol (CAS 138071-82-6) Customer List
Table 72. Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Region (2023-2028) & (M L)
Table 73. Global Gadobutrol (CAS 138071-82-6) Sales Market Forecast by Region
Table 74. Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Gadobutrol (CAS 138071-82-6) Sales Forecast by Country (2023-2028) & (M L)
Table 77. Americas Gadobutrol (CAS 138071-82-6) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Gadobutrol (CAS 138071-82-6) Sales Forecast by Region (2023-2028) & (M L)
Table 79. APAC Gadobutrol (CAS 138071-82-6) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Gadobutrol (CAS 138071-82-6) Sales Forecast by Country (2023-2028) & (M L)
Table 81. Europe Gadobutrol (CAS 138071-82-6) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Forecast by Country (2023-2028) & (M L)
Table 83. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Type (2023-2028) & (M L)
Table 85. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Application (2023-2028) & (M L)
Table 89. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bayer HealthCare Pharmaceuticals Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Product Offered
Table 94. Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 95. Bayer HealthCare Pharmaceuticals Main Business
Table 96. Bayer HealthCare Pharmaceuticals Latest Developments
Table 97. SWAPNROOP DRUGS & PHARMACEUTICALS Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 98. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product Offered
Table 99. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 100. SWAPNROOP DRUGS & PHARMACEUTICALS Main Business
Table 101. SWAPNROOP DRUGS & PHARMACEUTICALS Latest Developments
Table 102. Manus Aktteva Biopharma Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 103. Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Product Offered
Table 104. Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 105. Manus Aktteva Biopharma Main Business
Table 106. Manus Aktteva Biopharma Latest Developments
Table 107. Jilin Tely Imp & Exp Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 108. Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Product Offered
Table 109. Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 110. Jilin Tely Imp & Exp Main Business
Table 111. Jilin Tely Imp & Exp Latest Developments
Table 112. JinYan Chemicals (ShangHai) Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 113. JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Product Offered
Table 114. JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 115. JinYan Chemicals (ShangHai) Main Business
Table 116. JinYan Chemicals (ShangHai) Latest Developments
Table 117. BOC Sciences Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 118. BOC Sciences Gadobutrol (CAS 138071-82-6) Product Offered
Table 119. BOC Sciences Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 120. BOC Sciences Main Business
Table 121. BOC Sciences Latest Developments
Table 122. LGM Pharma Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 123. LGM Pharma Gadobutrol (CAS 138071-82-6) Product Offered
Table 124. LGM Pharma Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 125. LGM Pharma Main Business
Table 126. LGM Pharma Latest Developments
Table 127. Advanced Technology & Industrail Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 128. Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Product Offered
Table 129. Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 130. Advanced Technology & Industrail Main Business
Table 131. Advanced Technology & Industrail Latest Developments
Table 132. MedKoo Biosciences Basic Information, Gadobutrol (CAS 138071-82-6) Manufacturing Base, Sales Area and Its Competitors
Table 133. MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Product Offered
Table 134. MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2022)
Table 135. MedKoo Biosciences Main Business
Table 136. MedKoo Biosciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Gadobutrol (CAS 138071-82-6)
Figure 2. Gadobutrol (CAS 138071-82-6) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gadobutrol (CAS 138071-82-6) Sales Growth Rate 2017-2028 (M L)
Figure 7. Global Gadobutrol (CAS 138071-82-6) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Gadobutrol (CAS 138071-82-6) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Figure 10. Product Picture of Pharmacy Bulk Packages (30 mL and 65 mL)
Figure 11. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2021
Figure 12. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type (2017-2022)
Figure 13. Gadobutrol (CAS 138071-82-6) Consumed in Adults
Figure 14. Global Gadobutrol (CAS 138071-82-6) Market: Adults (2017-2022) & (M L)
Figure 15. Gadobutrol (CAS 138071-82-6) Consumed in Children
Figure 16. Global Gadobutrol (CAS 138071-82-6) Market: Children (2017-2022) & (M L)
Figure 17. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Figure 18. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application in 2021
Figure 19. Gadobutrol (CAS 138071-82-6) Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company in 2021
Figure 21. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Geographic Region in 2021
Figure 23. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2017-2022)
Figure 24. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country/Region in 2021
Figure 25. Americas Gadobutrol (CAS 138071-82-6) Sales 2017-2022 (M L)
Figure 26. Americas Gadobutrol (CAS 138071-82-6) Revenue 2017-2022 ($ Millions)
Figure 27. APAC Gadobutrol (CAS 138071-82-6) Sales 2017-2022 (M L)
Figure 28. APAC Gadobutrol (CAS 138071-82-6) Revenue 2017-2022 ($ Millions)
Figure 29. Europe Gadobutrol (CAS 138071-82-6) Sales 2017-2022 (M L)
Figure 30. Europe Gadobutrol (CAS 138071-82-6) Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales 2017-2022 (M L)
Figure 32. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue 2017-2022 ($ Millions)
Figure 33. Americas Gadobutrol (CAS 138071-82-6) Sales Market Share by Country in 2021
Figure 34. Americas Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country in 2021
Figure 35. United States Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Gadobutrol (CAS 138071-82-6) Sales Market Share by Region in 2021
Figure 40. APAC Gadobutrol (CAS 138071-82-6) Revenue Market Share by Regions in 2021
Figure 41. China Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Country in 2021
Figure 48. Europe Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country in 2021
Figure 49. Germany Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country in 2021
Figure 56. Egypt Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Gadobutrol (CAS 138071-82-6) in 2021
Figure 62. Manufacturing Process Analysis of Gadobutrol (CAS 138071-82-6)
Figure 63. Industry Chain Structure of Gadobutrol (CAS 138071-82-6)
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 1. Picture of Gadobutrol (CAS 138071-82-6)
Figure 2. Gadobutrol (CAS 138071-82-6) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gadobutrol (CAS 138071-82-6) Sales Growth Rate 2017-2028 (M L)
Figure 7. Global Gadobutrol (CAS 138071-82-6) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Gadobutrol (CAS 138071-82-6) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Figure 10. Product Picture of Pharmacy Bulk Packages (30 mL and 65 mL)
Figure 11. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2021
Figure 12. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type (2017-2022)
Figure 13. Gadobutrol (CAS 138071-82-6) Consumed in Adults
Figure 14. Global Gadobutrol (CAS 138071-82-6) Market: Adults (2017-2022) & (M L)
Figure 15. Gadobutrol (CAS 138071-82-6) Consumed in Children
Figure 16. Global Gadobutrol (CAS 138071-82-6) Market: Children (2017-2022) & (M L)
Figure 17. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2017-2022)
Figure 18. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application in 2021
Figure 19. Gadobutrol (CAS 138071-82-6) Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company in 2021
Figure 21. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Geographic Region in 2021
Figure 23. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2017-2022)
Figure 24. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country/Region in 2021
Figure 25. Americas Gadobutrol (CAS 138071-82-6) Sales 2017-2022 (M L)
Figure 26. Americas Gadobutrol (CAS 138071-82-6) Revenue 2017-2022 ($ Millions)
Figure 27. APAC Gadobutrol (CAS 138071-82-6) Sales 2017-2022 (M L)
Figure 28. APAC Gadobutrol (CAS 138071-82-6) Revenue 2017-2022 ($ Millions)
Figure 29. Europe Gadobutrol (CAS 138071-82-6) Sales 2017-2022 (M L)
Figure 30. Europe Gadobutrol (CAS 138071-82-6) Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales 2017-2022 (M L)
Figure 32. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue 2017-2022 ($ Millions)
Figure 33. Americas Gadobutrol (CAS 138071-82-6) Sales Market Share by Country in 2021
Figure 34. Americas Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country in 2021
Figure 35. United States Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Gadobutrol (CAS 138071-82-6) Sales Market Share by Region in 2021
Figure 40. APAC Gadobutrol (CAS 138071-82-6) Revenue Market Share by Regions in 2021
Figure 41. China Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Country in 2021
Figure 48. Europe Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country in 2021
Figure 49. Germany Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country in 2021
Figure 56. Egypt Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Gadobutrol (CAS 138071-82-6) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Gadobutrol (CAS 138071-82-6) in 2021
Figure 62. Manufacturing Process Analysis of Gadobutrol (CAS 138071-82-6)
Figure 63. Industry Chain Structure of Gadobutrol (CAS 138071-82-6)
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
